AU2912695A - Oral compositions of h2-antagonists - Google Patents

Oral compositions of h2-antagonists

Info

Publication number
AU2912695A
AU2912695A AU29126/95A AU2912695A AU2912695A AU 2912695 A AU2912695 A AU 2912695A AU 29126/95 A AU29126/95 A AU 29126/95A AU 2912695 A AU2912695 A AU 2912695A AU 2912695 A AU2912695 A AU 2912695A
Authority
AU
Australia
Prior art keywords
antagonists
oral compositions
oral
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU29126/95A
Inventor
Henry C Caldwell
Ashok J Desai
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU2912695A publication Critical patent/AU2912695A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/143—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
AU29126/95A 1994-08-12 1995-06-28 Oral compositions of h2-antagonists Abandoned AU2912695A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US28871194A 1994-08-12 1994-08-12
US288711 1994-08-12
PCT/US1995/008142 WO1996004888A1 (en) 1994-08-12 1995-06-28 Oral compositions of h2-antagonists

Publications (1)

Publication Number Publication Date
AU2912695A true AU2912695A (en) 1996-03-07

Family

ID=23108303

Family Applications (1)

Application Number Title Priority Date Filing Date
AU29126/95A Abandoned AU2912695A (en) 1994-08-12 1995-06-28 Oral compositions of h2-antagonists

Country Status (2)

Country Link
AU (1) AU2912695A (en)
WO (1) WO1996004888A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5622980A (en) * 1993-08-17 1997-04-22 Applied Analytical Industries, Inc. Oral compositions of H2-antagonists
AU9187598A (en) * 1997-09-30 1999-04-23 Daiichi Pharmaceutical Co., Ltd. Oral preparation

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7981391A (en) * 1990-06-22 1992-01-23 Beecham Group Plc Novel treatment
US5229137A (en) * 1992-05-06 1993-07-20 Brigham And Women's Hospital, Inc. Methods and pharmaceutical compositions for treating episodic heartburn
GB9211148D0 (en) * 1992-05-26 1992-07-08 Smithkline Beecham Plc Novel treatment

Also Published As

Publication number Publication date
WO1996004888A1 (en) 1996-02-22

Similar Documents

Publication Publication Date Title
AU4016095A (en) Oral compositions
AU3650895A (en) Oral compositions
AU6725496A (en) Peroxidase-activating oral compositions
AU2372095A (en) Oral compositions
AU4928396A (en) Oral compositions
AU4287096A (en) Oral compositions of h2-antagonists
AU7842794A (en) Oral compositions
AU5804194A (en) Oral compositions
AU4121096A (en) Thickened peracid compositions
AU7256296A (en) Use of metallofluorocomplexes for dental compositions
AU5487896A (en) Dentifrice compositions
AU5151293A (en) Oral hygiene composition
AU4121296A (en) Thickened peracid compositions
AU6776494A (en) Oral compositions
AU2458595A (en) Oral hygiene composition
AU4702496A (en) Oral compositions of h2-antagonists
AUPN029994A0 (en) Alkypolysaccharide derivatives & compositions
AU2763395A (en) Cleaning compositions
AU2882895A (en) Oral hygiene composition
AU5560596A (en) Formed compositions
AU3890395A (en) Antimicrobial oral compositions
AU2427895A (en) Oral compositions
AU7345094A (en) Oral compositions
AU4756996A (en) Oral compositions
AU2790495A (en) Oral hygiene composition